Imprime PGG improves the efficacy of carboplatin, paclitaxel, and cetuximab chemoimmunotherapy of advanced non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Thomas, Michael [1 ]
Sadjadian, Parvis [2 ]
Kollmeier, Jens [3 ]
Hao, Zhonglin [4 ]
Patchen, Myra [5 ]
Lowe, Jamie [5 ]
Mattson, Paulette [5 ]
Huhn, Richard D. [5 ]
Bose, Nandita [5 ]
Antonysamy, Mary [5 ]
Gargano, Michele [5 ]
Gordon, Keith [5 ]
Schneller, Folker [6 ]
机构：
[1] Univ Clin Heidelberg, Heidelberg, Germany
[2] Johannes Wesling Klinikum Minden, Minden, Germany
[3] Helios Clin Emil von Behring, Berlin, Germany
[4] Georgia Hlth Sci Univ, Augusta, GA USA
[5] Biothera Inc, Eagan, MN USA
[6] Tech Univ Munich, Klinikum Rechts Isar, D-80290 Munich, Germany
来源：
CLINICAL CANCER RESEARCH | 2014年 / 20卷
关键词：
D O I：
10.1158/1078-0432.14AACRIASLC-A26
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A26
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)
    Jordi Rodon
    Charlotte D. Jacobs
    Quincy Chu
    Eric K. Rowinsky
    Arturo Lopez-Anaya
    Chris H. Takimoto
    Heather A. Wakelee
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 825 - 834
  • [22] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [23] Meloxicam in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer
    Takahashi, T
    Ueda, S
    Kogure, Y
    Ebisawa, M
    Asai, G
    Yamamoto, N
    LUNG CANCER, 2005, 49 : S271 - S271
  • [24] EFFICACY OF CARBOPLATIN plus WEEKLY NAB-PACLITAXEL FOR ELDERLY ADVANCED/RECURRENT NON-SMALL CELL LUNG CANCER (E-NSCLC)
    Shibata, Kazuhiko
    Shibata, Yoshihiro
    Takase, Misae
    Takahashi, Miyuki
    ANNALS OF ONCOLOGY, 2014, 25
  • [25] Paclitaxel and carboplatin: A phase I study in advanced non-small cell lung cancer
    Paccagnella, A
    Favaretto, A
    Oniga, F
    Ossana, L
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 76 - 79
  • [26] Paclitaxel and carboplatin in nonoperable non-small cell lung cancer
    Kosmidis, P
    Mylonakis, N
    Fountzilas, G
    Samantas, E
    Athanasiadis, A
    Skarlos, D
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 16 - 18
  • [27] Triplet chemotherapy with paclitaxel, gemcitabine and carboplatin in advanced non-small cell lung cancer
    Bunn, PA
    Kelly, K
    Mikhaeel, N
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 21 - 21
  • [28] Efficacy and safety of weekly nab-paclitaxel plus carboplatin advanced non-small cell lung cancer
    Satouchi, Miyako
    Okamoto, Isamu
    Sakai, Hiroshi
    Yamamoto, Nobuyuki
    Ichinose, Yukito
    Ohmatsu, Hironobu
    Nogami, Naoyuki
    Takeda, Koji
    Mitsudomi, Tetsuya
    Kasahara, Kazuo
    Negoro, Shunichi
    LUNG CANCER, 2013, 81 (01) : 97 - 101
  • [29] A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): SWOG S0819
    Herbst, Roy
    Redman, Mary
    Kim, Edward S.
    Semrad, Thomas J.
    Bazhenova, Lyudmila
    Masters, Gregory
    Oettel, Kurt
    Guaglianone, Perry
    Reynolds, Christopher
    Karnad, Anand
    Arnold, Susanne M.
    Varella-Garcia, Marileila
    Moon, James
    Mack, Philip C.
    Blanke, Charles D.
    Hirsch, Fred R.
    Gandara, David R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S795 - S795
  • [30] Phase II study of cetuximab in combination with carboplatin and docetaxel for patients with advanced/metastatic non-small cell lung cancer (NSCLC)
    Belani, C. P.
    Ramalingam, S.
    Schreeder, M.
    Steis, R.
    Guidice, R.
    Marshland, T.
    Butler, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345